Blue Owl Capital Holdings »

Larimar Therapeutics shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Larimar Therapeutics shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Larimar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Larimar Therapeutics held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Larimar Therapeutics by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.9M 976k 1.96

More positions owned by Blue Owl Capital Holdings

Aktis Oncology (AKTS)
Larimar Therapeutics (LRMR)
Engene Holdings
Nuveen Churchill Direct Lend Com Shs (NCDL)
Cullinan Oncology (CGEM)
Owl Rock Capital Corporation (OBDC)
Maplight Therapeutics (MPLT)
Compass Therapeutics (CMPX)
Context Therapeutics (CNTX)
Holley (HLLY)
Eyepoint Com New (EYPT)
Corvus Pharmaceuticals (CRVS)
Conduent Incorporate (CNDT)
Ultragenyx Pharmaceutical (RARE)
Aquestive Therapeutics (AQST)

View all positions for Blue Owl Capital Holdings

Top funds holding Larimar Therapeutics

Blue Owl Capital Holdings
Simplex Trading
Group One Trading

View all funds holding Larimar Therapeutics